Company: PGEN
Filing Date: 2025-03-19
Form Type: 10-K
Source: 0001356090-25-000007
Chunk: 204

Company: PRECIGEN, INC.
Filing Date: 2025-03-19
Form: 10-K
Item: Item 12
Chunk 204
---
 segment performance, it has included this measure in its discussion of segment operating results. The Company has also disclosed revenues from external customers and intersegment revenues for each reportable segment, if any. The Company's CODM is its President and Chief Executive Officer. The CODM does not use total assets by segment to evaluate segment performance or allocate resources, and accordingly, these amounts are not required to be disclosed. The CODM uses Segment Adjusted EBITDA for each segment in order to evaluate performance and allocate resources, reviewing actual results to budget throughout the year as an input into making those decisions.For the year ended December 31, 2024, the Company's reportable segments were (i) Biopharmaceuticals and (ii) Exemplar. These identified reportable segments met the quantitative thresholds to be reported separately for the year ended December 31, 2024. See Note 2 for a description of Biopharmaceuticals and Exemplar. Segment Adjusted EBITDA by reportable segment was as follows:

F-42

Year Ended December 31, 2024BiopharmaceuticalsExemplarTotalRevenues from external customers/Total segment revenues$— $3,925 $3,925 Less:Salaries, benefits and other payroll expenses, including severance cost(43,363)(2,879)Rent and Utilities(3,195)(706)Capital Expenditures(8,477)(47)Other Segment Adjusted EBITDA(27,252)(1,222)Segment Adjusted EBITDA$(82,287)$(929)$(83,216)Year Ended December 31, 2023BiopharmaceuticalsExemplarTotalRevenues from external customers/Total segment revenues$75 $6,150 $6,225 Less:Salaries, benefits and other payroll expenses(40,276)(3,774)Rent and Utilities(2,854)(801)Capital Expenditures(1,251)(187)Other Segment Adjusted EBITDA(31,033)(2,114)Segment Adjusted EBITDA$(75,339)$(726)$(76,065)Year Ended December 31, 2022BiopharmaceuticalsExemplarTotalRevenues from external customers/Total segment revenues$14,894 $12,015 $26,909 Less:Salaries, benefits and other payroll expenses(37,624)(3,771)Rent and